NFKB1 and cancer: ROS further modulate the nuclear factor kappa B (NF-κB) pathway (Lingappan, 2018) and induce oxidative modifications of transcription factors (e.g., Nrf2, p53), altering their stability and activity in cancer-related processes (Humpton et al., 2022).